Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Aug 26;61(5):776–783. doi: 10.1093/jrr/rraa067

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Fig. 1. — A 70-year-old female with HCC treated with TACE. (A) Abdominal CT scan showed an enlarged lymph node metastasis in the retropanceratic space with duodenal obstruction (circle). (B) Abdominal CT with dose distribution curves of SBRT delivered with IMRT. The innermost line was the 100% isodose line (yellow line). SBRT was administered with 45 Gy in 6 fractions (BED, 78.8 Gy₁₀). (C) Abdominal CT at 2 months following the completion of SBRT showed a reduction of the metastatic node size (circle), and the RECIST response rate was partial response (PR). The duodenal obstruction was relieved. (D) The metastatic node disappeared on routine follow-up CT at 9 months following the completion of SBRT (asterisk).